(Q104911674)

http://api.crossref.org/works/10.1007%2Fs11418-005-0027-x

1 reference

1 reference

1 reference

1 reference

ZVWPGRDRBHPVSQ-INXOKTBLSA-N

1 reference

VOYHSJDAXOFLAT-IALHOLLZSA-N

1 reference

1 reference

1 reference

IWDYQBDCEDNTDP-AOSWIFJRSA-N

1 reference

AZIGQTILUNTIQH-VJKRGORSSA-N

1 reference

1 reference

RWXIFXNRCLMQCD-PRSAKGRSSA-N

1 reference

Panaxadiol-3-yl beta-glucopyranoside

1 reference

JXRIVFVBUUJAGK-RQYLRFHSSA-N

1 reference

NODILNFGTFIURN-DIZIAPBASA-N

1 reference

1 reference

1 reference

SXNNDEIXKBANEP-OEHDJSDTSA-N

1 reference

YURJSTAIMNSZAE-ZTKSRHMUSA-N

1 reference

18-Norpregnan-20-one, 6-(beta-D-glucopyranosyloxy)-3,12-dihydroxy-4,4,8,14-tetramethyl-, (3beta,5alpha,6alpha,12beta)-

1 reference

(20S)-20-(beta-D-Glucopyranosyloxy)-3beta-[(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]dammar-24-en-12beta-ol

1 reference

1 reference

(20S)-ginsenoside Rh1

1 reference

1 reference

(20E)-6alpha-(beta-D-Glucopyranosyloxy)-3beta,12beta,25-trihydroxydammara-20(22)-ene

1 reference

1 reference

1 reference

KEQXHOWXGVHEHV-GGEOJOSYSA-N

1 reference

XBGLCVZQMWKHFC-UBJQIMRZSA-N

1 reference

(2R,3S,4R,5R,6S)-2-(hydroxymethyl)-6-[(2R)-6-methyl-2-[(6R,10R,12S,13R,14R,17S)-3,6,12-trihydroxy-4,4,10,14,17-pentamethyl-2,3,5,6,7,8,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol

1 reference

QUNSGRLNZDSQJC-ZSTWOJQOSA-N

1 reference

UZIOUZHBUYLDHW-MGCORQOGSA-N

1 reference

1 reference

1 reference

12,20-Dihydroxy-4,4,14-trimethyl-18-norcholest-24-en-3-yl 2-O-[3-deoxy-3-(hydroxymethyl)hexopyranosyl]hexopyranoside

1 reference

(2R,3R,4R,5R,6S)-2-{[(1S,3aR,3bR,5S,5aR,7S,9aS,9bS,11R,11aR)-1-[(2R,3E)-2,6-dihydroxy-6-methylhept-3-en-2-yl]-7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-dodecahydro-1H-cyclopenta[a]phenanthren-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

1 reference

NODILNFGTFIURN-INPQSWTGSA-N

1 reference

UIFSQNKEIFIEJO-NTGAWNEPSA-N

1 reference

PWAOOJDMFUQOKB-DMHRULFASA-N

1 reference

BIRZHRCAUBJIEK-MEGXYCSZSA-N

1 reference

1 reference

1 reference

(2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9S,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

1 reference

GDMBPUARLSVEAE-GJXAEJTASA-N

1 reference

YFXPRCDUBFSHJY-AXNFAZMZSA-N

1 reference

ZTQSADJAYQOCDD-XTHRNRJFSA-N

1 reference

1 reference

TXQLFMCRDJSJDN-LHBJRVFJSA-N

1 reference

HERICYNRBVMDFO-RQGKADFNSA-N

1 reference

NTAJLZDIWQCQKN-KXLUHDCESA-N

1 reference

JDCPEKQWFDWQLI-BSBOBSSASA-N

1 reference

LDCGQTUTAWJKFH-VKXLEPQWSA-N

1 reference

1 reference

MGEVFIHLEFXNMC-UHFFFAOYSA-N

1 reference

KEQXHOWXGVHEHV-UHFFFAOYSA-N

(+)-Notoginsenoside R6

1 reference

1 reference

1 reference

JXRIVFVBUUJAGK-UHFFFAOYSA-N

(+)-Notoginsenoside I

1 reference

1 reference

1 reference

1 reference

1 reference

(20R)-Ginsenoside Rh2

1 reference

1 reference

1 reference

NTAJLZDIWQCQKN-UHFFFAOYSA-N

1 reference

NODILNFGTFIURN-UHFFFAOYSA-N

1 reference

NPZAABKZLIBPQV-UHFFFAOYSA-N

1 reference

SXNNDEIXKBANEP-UHFFFAOYSA-N

1 reference

1 reference

XYDGLABNHGXTRN-UHFFFAOYSA-N

1 reference

BIRZHRCAUBJIEK-UHFFFAOYSA-N

1 reference

AZIGQTILUNTIQH-UHFFFAOYSA-N

1 reference

FBFMBWCLBGQEBU-UHFFFAOYSA-N

1 reference

1 reference

2-({[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-{[2-(11-hydroxy-3a,3b,6,6,9a-pentamethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-dodecahydro-1H-cyclopenta[a]phenanthren-1-yl)-6-methylhept-4-en-2-yl]oxy}oxane-3,4,5-triol

1 reference

1 reference

1 reference

QIJZJJDYRMOHTP-UHFFFAOYSA-N

1 reference

(+)-Notoginsenoside D

1 reference

2-[[3,12-dihydroxy-17-(6-hydroxy-6-methylhept-2-en-2-yl)-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

1 reference

1 reference

JDCPEKQWFDWQLI-UHFFFAOYSA-N

1 reference

MYCOIXOUZMKBTK-UHFFFAOYSA-N

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

Chong-Zhi Wang

1

1 reference

http://api.crossref.org/works/10.1007%2Fs11418-005-0027-x

Eryn McEntee

2

1 reference

http://api.crossref.org/works/10.1007%2Fs11418-005-0027-x

Sheila Wicks

3

1 reference

http://api.crossref.org/works/10.1007%2Fs11418-005-0027-x

Ji-An Wu

4

1 reference

http://api.crossref.org/works/10.1007%2Fs11418-005-0027-x

Chun-Su Yuan

5

1 reference

http://api.crossref.org/works/10.1007%2Fs11418-005-0027-x

publication date

16 February 2006

1 reference

16 September 2022

Journal of Natural Medicines

1 reference

http://api.crossref.org/works/10.1007%2Fs11418-005-0027-x

volume

60

1 reference

http://api.crossref.org/works/10.1007%2Fs11418-005-0027-x

page(s)

97-106

1 reference

http://api.crossref.org/works/10.1007%2Fs11418-005-0027-x

issue

2

1 reference

http://api.crossref.org/works/10.1007%2Fs11418-005-0027-x

cites work

HPTLC fingerprint identification of commercial ginseng drugs - reinvestigation of HPTLC of ginsenosides

1 reference

stated in

COCI